Another Major Drug Approval for Regeneron
Congratulations to BCW member Regeneron on the approval of an important new drug to help patients with rheumatoid arthritis. The U.S. Food and Drug Administration has approved the human antibody drug sarilumab, developed by Regeneron Pharmaceuticals Inc. in Westchester and its French pharmaceutical partner Sanofi and trademarked as Kevzara, to treat adult patients with moderately to severely active rheumatoid arthritis.
The FDA approval came less than two months after the federal agency approved Regeneron’s and Sanofi’s human antibody dupilumab, marketed as Dupixent, as the first biologic medicine used to treat the debilitating itching and widespread rashes afflicting adults with moderate to severe cases of atopic dermatitis.
Similar News Items
BCW Member KeyBank has announced its newest branch, located at 1 North Main Street, Port Chester in the Port & Main building. The new 3,975 square-foot full-service branch will provide clients with a full range of financial products and services, including personal and business banking, investment solutions, and mortgage lending. The facility will include state-of-the-art […]
Jack A. Martinelli has been awarded the BCW’s prestigious Ambassador of the Year Award. The award was presented at the BCW’s Annual New Year Blast held on January 9 at the Surf Club in New Rochelle. Martinelli is the Director of Business Development for 914 INC Magazine. Also known as The Business Magazine of Westchester, 914 INC […]
A new real estate report authored by RM Friedland reveals the explosive growth of housing in Westchester County since 2021, with about 12,500 new residential units delivered and another 15,000 units under construction. Representatives from RM Friedland delivered their findings on Tuesday in White Plains at the Business Council of Westchester’s and the Fordham Real […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.